Generex Biotechnology Announces Plans to Establish the NuGenerex Diabetes Research Center in Collaboration With Arizona Endocrinology Group & Paradise Valley Medical Family Medicine

Integrated, collaborative data systems enable population analytics Generex plans to accelerate the clinical development of Oral-Lyn-2 for Type-2 diabetes and Altsulin® for Type-1 diabetes MIRAMAR, Fla., Sept. 27, 2019 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (OTCQB:GNBT) […]


EastGate Biotech Receives Regulatory Approval to Initiate a Phase III 90-day Clinical Trial on Insugin, Its Liquid Insulin Mouth Rinse Solution

The Marketing Application Approval in Pakistan will follow subject to completion of the Phase III clinical study that will include up to 200 Type 2 patients […]


Victoria Gold Corp (TSXV: VIT)(OTC: VITFF) CEO Interview Update

WSA caught up with John McConnell, CEO and President of Victoria Gold Corp to discuss recent progress on their Eagle Gold project and provide investors an update since his previous interview from 18 months ago. He laid out key goals over the next several months and provided insight on VIT’s management, operations, and strategy. […]

News Feed

EastGate Biotech Announces Appointment of Bill Abajian to Lead Licensing and Marketing Phase as Chief Operating Officer

WEST CALDWELL, NJ and TORONTO, ON, Sept. 04, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery […]